MARIA NUNEZ: Open Payments
NPI 1750982732 · BELLEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 58 payments from 16 companies in 2025. Trend: 2023 $235 · 2024 $900 · 2025 $1,109
Food & beverage: $1,109
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $183 |
| Insulet Corporation | 7 | $161 |
| Corcept Therapeutics | 6 | $123 |
| Tandem Diabetes Care, Inc. | 4 | $96 |
| Mannkind Corporation | 5 | $89 |
| Amgen Inc. | 5 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $85 |
| Lilly USA, LLC | 5 | $83 |
| Xeris Pharmaceuticals, Inc. | 3 | $50 |
| SANOFI-AVENTIS U.S. LLC | 2 | $34 |
Products named: Omnipod, Ozempic, Korlym, t:slim X2 Insulin Pump with Control-IQ, AFREZZA, JARDIANCE, MOUNJARO, TEPEZZA.
Industry payments across NJ — which companies pay providers there.
